| Literature DB >> 35943717 |
Mitsutoshi Oguri1, Hideki Ishii2, Takuro Shigematsu3, Rin Fujita3, Yuichiro Koyama3, Takeshi Katagiri3, Yoshihiro Ikai3, Yusuke Fujikawa3, Hiroshi Takahashi4, Yoriyasu Suzuki5, Toyoaki Murohara6.
Abstract
Percutaneous coronary intervention (PCI) requires multiple staff members, including interventional cardiologists, with the physical burden of heavy protective measures to minimize radiation exposure. Here, we aimed to investigate the safety of task sharing with clinical engineers (CEs) working as 1st assistant during ad hoc PCI. We retrospectively included 286 patients who underwent ad hoc PCI following diagnostic catheterization for coronary artery disease between April 2019 and March 2021. Procedural complications including coronary perforation or rupture, myocardial infarction, cerebral embolism, cardiovascular death, decreased kidney function, and radiation parameters were compared between the two clinical settings [CE group, CEs as the 1st assistant from the beginning of diagnostic coronary angiography to the end of PCI vs. doctor (DR) group, others]. There was no increase in the ratio of procedural complications in the CE group (1.7%) versus the DR group (1.2%). Fluorescence time and radiation exposure dose were significantly reduced in the CE group {25 min [interquartile range (IQR), 19-35 min] vs. 28 min (IQR, 20-39 min), P = 0.036; 908 mGy (IQR, 654-1326 mGy) vs. 1062 mGy (IQR, 732-1594 mGy), P = 0.049}. The median amount of contrast medium was significantly reduced in the CE group [100 mL (IQR, 80-119 mL) vs. 110 mL (IQR 90-140 mL), P < 0.001]. After propensity matching, fluorescence time, radiation exposure dose, and contrast medium amount were similar between groups. Task sharing with CEs as the 1st assistant during ad hoc PCI could contribute to clinical safety in patients with coronary artery disease.Entities:
Keywords: Clinical engineer; Percutaneous coronary intervention; Safety
Year: 2022 PMID: 35943717 PMCID: PMC9360703 DOI: 10.1007/s12928-022-00884-w
Source DB: PubMed Journal: Cardiovasc Interv Ther ISSN: 1868-4297
Fig. 1The study flowchart. PCI percutaneous coronary intervention
Training program
| Process | Detailed contents | |
|---|---|---|
| 1 | In-deflator preparation | Prepare an in-deflator with 5 mL of contrast media and 5 mL of saline |
| 2 | Sheath introducer preparation | Confirm with raising a voice, and flush with saline |
| 3 | Sheath exchange | Assist operator during exchanging the sheath, if needed |
| 4 | Confirm with raising a voice for additional heparin introduction by nurse | |
| 5 | Guide catheter preparation | Flush with saline and connect with the Y-connecting tube |
| 6 | Guide catheter advance | Assist operator during advance of the guide catheter |
| 7 | Reference images storage | Store reference images according to operator’s instruction |
| 8 | Prepare coronary guidewire(s) | Be sure to raise a voice before taking it out from the case. And then, flush with saline |
| 9 | Intravascular ultrasound or optimal coherence technology preparation | Be sure to raise a voice before taking out from the case, then flush with saline and check if it works |
| 10 | Thrombus aspiration catheter preparation | Be sure to raise a voice before removing it from the case. Flush with saline |
| 11 | Balloon preparation | Be sure to repeat the exact size with raising a voice before taking out from the case. Connect with an in-deflator and remove air |
| 12 | Balloon operation (including drug-coated balloon and scoring balloon) | Inflate following operator’s instruction. Be sure to repeat the indicated pressure exactly with raising a voice. Check the fluorescent image if the balloon dilates while checking the pressure of in-deflator |
| 13 | Stent preparation | Be sure to repeat the exact size with raising a voice before taking out from the case Connect with an in-deflator and remove air (before or after advancing to the lesion) |
| 14 | Stent operation | Inflate following operator’s instruction. Be sure to repeat the indicated pressure exactly with raising a voice. Check the fluorescent image if the stent dilates while checking the pressure of in-deflator |
| 15 | Review | Review the PCI process with other stuff in the catheterization room |
PCI percutaneous coronary intervention
Characteristics of the study subjects
| CE group | DR group | ||
|---|---|---|---|
| Age, years | 72 (64 − 79) | 70 (56 − 79) | 0.181 |
| Male sex, % | 69.0 | 77.7 | 0.100 |
| Current or former smoker, % | 51.7 | 56.5 | 0.429 |
| Body mass index, kg/m2 | 24.3 (22.1 − 26.6) | 24.2 (22.1 − 26.3) | 0.471 |
| Dyslipidemia, % | 77.6 | 61.2 | 0.004 |
| Type 2 diabetes mellitus, % | 44.8 | 42.9 | 0.752 |
| Hypertension, % | 86.2 | 78.8 | 0.112 |
| Chronic heart failure, % | 6.0 | 10.0 | 0.282 |
| Previous myocardial infarction, % | 25.0 | 13.5 | 0.014 |
| Coronary bypass surgery, % | 0.9 | 0.6 | 1.000 |
| Diagnosis (AMI/others), % | 37.9/62.1 | 60.6/39.4 | < 0.001 |
Experience of operator in PCI (< 5 years/ ≥ 5 to < 10 years/ ≥ 10 years), % | 3.5/56.0/40.5 | 15.3/49.4/35.3 | 0.006 |
| Multiple vessel disease, % | 41.4 | 50.6 | 0.125 |
| Coronary lesions | 0.264 | ||
| Left anterior descending artery, % | 48.3 | 56.5 | 0.173 |
| Right coronary artery, % | 30.2 | 21.8 | 0.108 |
| Left circumflex artery, % | 20.7 | 21.8 | 0.828 |
| ACC/AHA lesion type B2 or C, % | 44.0 | 40.6 | 0.570 |
| Bifurcation lesion, % | 16.4 | 16.5 | 1.000 |
| Radial artery access, % | 94.0 | 90.6 | 0.379 |
| Imaging device use, % | 98.3 | 100 | 0.164 |
Categorical variables are described as percentages, and continuous variables are presented as median and 25–75th percentile range
ACC/AHA American College of Cardiology/American Heart Association, AMI acute myocardial infarction, CE clinical engineer, DR doctor, PCI percutaneous coronary intervention
Clinical outcomes
| CE group | DR group | ||
|---|---|---|---|
| Procedural complications, % | 1.7 | 1.2 | 1.000 |
| Coronary perforation or rupture, n | 1 | 1 | |
| Myocardial infarction, n | 1 | 0 | |
| Cerebral embolism, n | 0 | 1 | |
| Cardiovascular death, n | 0 | 0 | |
| Fluorescence time, min | 25 (19–35) | 28 (20–39) | 0.036 |
| Radiation exposure dose, mGy | 908 (654–1326) | 1062 (732–1594) | 0.049 |
| Procedural time, min | 90 (75–120) | 105 (80–126) | 0.155 |
| Contrast medium dose, mL | 100 (80–119) | 110 (90–140) | < 0.001 |
| Before PCI | 0.88 (0.72–1.06) | 0.88 (0.76–1.02) | 0.832 |
| The day after PCI | 0.83 (0.68–0.97) | 0.82 (0.73–0.98) | 0.521 |
| Decreased kidney function, | 2 (1.7) | 2 (1.2) | 1.000 |
Categorical variables are described as percentages, while continuous variables are presented as median and 25–75th percentiles
CE clinical engineer, DR doctor, PCI percutaneous coronary intervention
Characteristics of the study subjects after propensity score matching
| CE group | DR group | ||
|---|---|---|---|
| Age, years | 72 (61 − 79) | 74 (58 − 81) | 0.578 |
| Male sex, % | 75.8 | 78.8 | 0.836 |
| Current or former smoker, % | 51.5 | 59.1 | 0.381 |
| Body mass index, kg/m2 | 24.6 (21.6 − 26.1) | 23.5 (21.1 − 24.8) | 0.130 |
| Dyslipidemia, % | 72.7 | 74.2 | 1.000 |
| Type 2 diabetes mellitus, % | 34.9 | 39.4 | 0.589 |
| Hypertension, % | 81.8 | 86.4 | 0.635 |
| Chronic heart failure, % | 6.1 | 7.6 | 1.000 |
| Previous myocardial infarction, % | 12.1 | 16.7 | 0.621 |
| Diagnosis (AMI/others), % | 48.5/51.5 | 47.0/53.0 | 0.862 |
| Experience of operator in PCI (< 5 years/ ≥ 5 to < 10 years/ ≥ 10 years), % | 6.1/54.5/39.4 | 4.6/54.5/40.9 | 0.922 |
| Multiple vessel disease, % | 48.5 | 54.6 | 0.486 |
| Coronary lesions | 0.915 | ||
| Left anterior descending artery, % | 53.0 | 51.5 | 0.862 |
| Right coronary artery, % | 25.8 | 24.2 | 1.000 |
| Left circumflex artery, % | 21.2 | 24.2 | 0.836 |
| ACC/AHA lesion type B2 or C, % | 45.5 | 33.3 | 0.154 |
| Bifurcation lesion, % | 13.6 | 15.2 | 1.000 |
| Radial artery access, % | 93.9 | 93.9 | 1.000 |
| Imaging device use, % | 98.5 | 100 | 1.000 |
Categorical variables are described as percentages, and continuous variables are presented as median and 25th–75th percentiles
ACC/AHA American College of Cardiology/American Heart Association AMI acute myocardial infarction, CE clinical engineer, DR doctor, PCI percutaneous coronary intervention
Clinical outcomes in propensity score matched groups
| CE group | DR group | ||
|---|---|---|---|
| Procedural complications, % | 0 | 1.5 | 1.000 |
| Coronary perforation or rupture, | 0 | 0 | |
| Periprocedural myocardial infarction, | 0 | 0 | |
| Cerebral embolism, | 0 | 1 | |
| Cardiovascular death, | 0 | 0 | |
| Fluorescence time, min | 26 (18 − 35) | 27 (19 − 38) | 0.794 |
| Radiation exposure dose, mGy | 915 (672 − 1408) | 960 (668 − 1444) | 0.928 |
| Procedural time, min | 100 (79 − 120) | 102 (75 − 120) | 0.848 |
| Contrast medium dose, mL | 100 (80 − 125) | 110 (85 − 130) | 0.703 |
| Before PCI | 0.90 (0.72 − 1.08) | 0.91 (0.77 − 1.09) | 0.530 |
| The day after PCI | 0.88 (0.66 − 1.03) | 0.84 (0.73 − 1.00) | 0.739 |
| Decreased kidney function, | 2 (3.0) | 2 (3.0) | 1.000 |
Categorical variables are described as percentages, and continuous variables are presented as median and 25th–75th percentiles
CE clinical engineer, DR doctor, PCI percutaneous coronary intervention
Patients’ clinical outcomes by period in propensity score matched groups
| CE group | DR group | CE group | DR group | |||
|---|---|---|---|---|---|---|
| Period | From April 2019 to March 2020 | From April 2020 to March 2021 | ||||
| Procedural complications, % | 0 | 2.4 | 1.000 | 0 | 0 | N/A |
| Contrast medium dose, mL | 100 (80–126) | 110 (89–120) | 0.997 | 98 (83–124) | 105 (81–140) | 0.508 |
| Fluorescence time, min | 25 (18–33) | 25 (17–39) | 0.920 | 32 (17–36) | 28 (23–35) | 0.934 |
| Radiation exposure dose, mGy | 905 (661–1343) | 867 (550–1416) | 0.605 | 959 (695–1564) | 981 (818–1744) | 0.588 |
| Procedural time, min | 100 (75–123) | 103 (73–120) | 0.654 | 98 (80–120) | 98 (80–120) | 0.868 |
Procedural complications included coronary perforation and rupture, myocardial infarction, cerebral embolism, and cardiovascular death
CE clinical engineer, DR doctor, N/A not applicable